arrow
F

Fumiaki Yokokawa

Novartis
H指数:35
被引数:3,069

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery and Preclinical Pharmacology of INE963, a Potent and Fast-Acting Blood-Stage Antimalarial with a High Barrier to Resistance and Potential for Single-Dose Cures in Uncomplicated Malaria
2022-03-0116
OAAI
NITD-688, a pan-serotype inhibitor of the dengue virus NS4B protein, shows favorable pharmacokinetics and efficacy in preclinical animal models

NITD-688是登革热病毒NS4B蛋白的泛血清型抑制剂,在临床前动物模型中显示出良好的药代动力学和疗效

2021-02-0346
PREAI
A Cyclic Phosphoramidate Prodrug of 2′-Deoxy-2′-Fluoro-2′-C- Methylguanosine for the Treatment of Dengue Virus Infection
2020-11-178
OAAI
Antiviral Nucleotide Incorporation by Recombinant Human Mitochondrial RNA Polymerase Is Predictive of Increased In Vivo Mitochondrial Toxicity Risk
2016-12-0115
OAAI
Structure-Based Design of Substituted Piperidines as a New Class of Highly Efficacious Oral Direct Renin Inhibitors

基于结构设计的取代哌啶类高效口服直接肾素抑制剂

2014-05-0828
OAAI
Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Novel Antitubercular Agents (vol 4, pg 451, 2013)
2014-02-111
OAAI
Discovery of Tetrahydropyrazolopyrimidine Carboxamide Derivatives As Potent and Orally Active Antitubercular Agents
2013-04-1145
OA
Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain
2008-08-2936
PREAI